Histone deacetylase inhibitors in cancer therapy

被引：45

作者：

Fouladi, Maryam ^{[1
]}

机构：

[1] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA

来源：

CANCER INVESTIGATION | 2006年 / 24卷 / 05期

关键词：

histone deacetylase inhibitors; chemotherapy; cancer;

D O I：

10.1080/07357900600814979

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：521 / 527

页数：7

共 91 条

[1] Rational development of histone deacetylase inhibitors as anticancer agents: A review [J].

Acharya, MR ;

Sparreboom, A ;

Venitz, J ;

Figg, WD .

MOLECULAR PHARMACOLOGY, 2005, 68 (04) :917-932

[2] Superior activity of the combination of histone deacetylase inhibitor LAQ824 and the FLT-3 kinase inhibitor PKC412 against human acute myelogenous leukemia cells with mutant FLT-3 [J].

Bali, P ;

George, P ;

Cohen, P ;

Tao, JG ;

Guo, F ;

Sigua, C ;

Vishvanath, A ;

Scuto, A ;

Annavarapu, S ;

Fiskus, W ;

Moscinski, L ;

Atadja, P ;

Bhalla, K .

CLINICAL CANCER RESEARCH, 2004, 10 (15) :4991-4997

[3] It's about time: Scheduling alters effect of histone deacetylase inhibitors on camptothecin-treated cells [J].

Bevins, RL ;

Zimmer, SG .

CANCER RESEARCH, 2005, 65 (15) :6957-6966

[4] Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies [J].

Bhalla, KN .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) :3971-3993

[5] The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin [J].

Butler, LM ;

Zhou, XB ;

Xu, WS ;

Scher, HI ;

Rifkind, RA ;

Marks, PA ;

Richon, VM .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (18) :11700-11705

[6] A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia [J].

Byrd, JC ;

Marcucci, G ;

Parthun, MR ;

Xiao, JJ ;

Klisovic, RB ;

Moran, M ;

Lin, TS ;

Liu, SJ ;

Sklenar, AR ;

Davis, ME ;

Lucas, DM ;

Fischer, B ;

Shank, R ;

Tejaswi, SL ;

Binkley, P ;

Wright, J ;

Chan, KK ;

Grever, MR .

BLOOD, 2005, 105 (03) :959-967

[7] Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer [J].

Cameron, EE ;

Bachman, KE ;

Myöhänen, S ;

Herman, JG ;

Baylin, SB .

NATURE GENETICS, 1999, 21 (01) :103-107

[8] Enhancement of xenograft tumor radiosensitivity by the histone deacetylase inhibitor MS-275 and correlation with histone hyperacetylation [J].

Camphausen, K ;

Scott, T ;

Sproull, M ;

Tofilon, PJ .

CLINICAL CANCER RESEARCH, 2004, 10 (18) :6066-6071

[9] NVP-LAQ824 is a potent novel histone deacetylase inhibitor with significant activity against multiple myeloma [J].

Catley, L ;

Weisberg, E ;

Tai, YT ;

Atadja, P ;

Remiszewski, S ;

Hideshima, T ;

Mitsiades, N ;

Shringarpure, R ;

LeBlanc, R ;

Chauhan, D ;

Munshi, NC ;

Schlossman, R ;

Richardson, P ;

Griffin, J ;

Anderson, KC .

BLOOD, 2003, 102 (07) :2615-2622

[10] Modulation of radiation response by histone deacetylase inhibition [J].

Chinnaiyan, P ;

Vallabhaneni, G ;

Armstrong, E ;

Huang, SM ;

Harari, PM .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (01) :223-229

← 1 2 3 4 5 6 7 8 9 10 →